ENSPRYNG
Solution for injection in pre-filled syringe, 120mg
RestrictedActive license
Active substance (INN)
satralizumab
Pharmaceutical form
Pharmaceutical formSolution for injection in pre-filled syringe
Strength120mg
PackagingUkupno 1 napunjeni injekcioni špric sa 1ml rastvora za injekciju u kartonskoj kutiji
ManufacturerF.Hoffmann-La Roche Ltd., Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L04AC19)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateNovember 2, 2022
Source: CInMED register